USPTO serial 98723761
PRIMER DESIGN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 16, 2025
- Examiner
- SCHNELL, BENJAMIN L
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PRIMER DESIGN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Eastleigh, England, GB
Eastleigh, England, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ben Natter
Ben Natter Haug Partners, LLP745 Fifth AvenueNew York, NY 10151United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for scientific purposes, namely, chemical preparations for use in performing nucleic acid polymerase chain reactions for pathogen detection, water and food analysis, detection of genetically modified organisms, species identification, and biothreat detection; chemical preparations for use in polymerase chain reactions for research and analysis purposes, not in the medical or veterinary fields; chemicals preparations for scientific purposes, namely, for use in the extraction of DNA and RNA from cells; diagnostic preparations for scientific use, namely, primers, reagents and other chemicals preparations for use in polymerase chain reactions for laboratory purposes; chemicals reagents for use in RNA and DNA analysis other than for medical or veterinary purposes; kits comprised of reagents and assays for biotechnological and chemical research purposes | ACTIVE | — |
| 005 | Chemical reagents for use in polymerase chain reactions for medical and veterinary purposes; chemicals reagents for medical and veterinary use, namely, chemical reagents for use in performing polymerase chain reactions for pathogen detection, detection of genetically modified organisms, species identification, and veterinary and medical disease detection; diagnostic preparations, namely, chemical preparations for use in the extraction of DNA and RNA from cells for medical and veterinary purposes; diagnostic preparations, namely, primers, reagents and other chemicals preparations for use in polymerase chain reactions for medical and veterinary purposes; chemicals reagents for use in RNA and DNA analysis for medical or veterinary purposes | ACTIVE | — |
| 009 | Laboratory apparatus for conducting polymerase chain reactions; laboratory apparatus for conducting quantitative or real-time polymerase chain reactions; medical laboratory research instruments for DNA analysis, namely, qPCR machines; laboratory apparatus for pathogen detection, water and food analysis, detection of genetically modified organisms, species identification and bio-threat detection; laboratory apparatus for use in extracting RNA and DNA; laboratory apparatus for pathogen detection for use in agricultural environments; laboratory instruments, namely, sample containers, vials, pipettes and stirrers in the nature of magnetic agitators used in the preparation of DNA and RNA samples for testing; laboratory instruments, namely, racks for holding sample pipettes and vials during testing; replacement parts and fittings for all the aforesaid goods; accessories for the aforesaid goods, namely, petri dishes, pipettes and test tubes; all the foregoing being for laboratory and research purposes | ACTIVE | — |
| 010 | Diagnostic apparatus for conducting polymerase chain reactions; diagnostic apparatus for conducting quantitative or real-time polymerase chain reactions; diagnostic apparatus namely, qPCR machines; diagnostic apparatus for pathogen detection, water and food analysis, detection of genetically modified organisms, species identification and bio-threat detection; diagnostic apparatus for use in extracting RNA and DNA; diagnostic apparatus for pathogen detection for use in agricultural environments; medical instruments, namely, sample containers, vials, dropping pipettes and stirrers in the nature of magnetic agitators used in the preparation of DNA and RNA samples for testing; medical instruments, namely, racks for holding medical sample tubes and vials during testing; replacement parts and fittings for all the aforesaid goods; accessories for the aforesaid goods, namely, dropping pipettes, medical sample tubes and vials; all the foregoing being for medical or veterinary purposes | ACTIVE | — |
| 040 | Custom manufacture of pharmaceuticals; information, advisory and consultation services in relation to the aforesaid; consulting services relating to pharmaceutical manufacturing; consulting services relating to commercial production of pharmaceuticals | ACTIVE | — |
| 042 | Research laboratory analysis, product design and development, advisory services, consulting services, and product quality testing services, all in the fields of medicine, pharmaceuticals, veterinary science and food technology; research and development services relating to chemistry, biology and micro-biology; research and development services in the fields of diagnostic chemicals, compounds and devices, measuring apparatus for use in product research and development; product development of medical diagnostic test apparatus; testing and product development of biopharmaceuticals; laboratory research in the field of biopharmaceuticals; scientific laboratory services relating to detection and identification of micro-organisms; immunodiagnostic services in the nature of diagnostic services for others for scientific research purposes; chemical, biological and microbiological assay services, namely, providing chemical, biological and micro-biological assay testing and diagnostic services for others for scientific research purposes; custom biochemical assay development, testing, optimisation and validation; custom design and development of chemical reagents and biochemical assays; research support services in the nature of assay development and validation, product development, and report generation in relation to scientific research, all in the fields of virology, immunological, biological and biochemical research; scientific research services for others in the nature of preparation of technical documents and reports for medical and pharmaceutical products; information, advisory and consultation services in relation to the aforesaid; Consulting services relating to clinical evaluation and testing in the nature of clinical trials; Consulting services relating to chemical stability studies being pharmaceutical studies; Consulting services relating to development of chemical production methods | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Primer Design Ltd.
- Other trademarks owned by Primer Design Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named PRIMER DESIGN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 16, 2025 | NRCS | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 16, 2025 | R.SR | REGISTERED-SUPPLEMENTAL REGISTER | Your mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application. |
| Nov 14, 2025 | CNTA | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | — |
| Nov 4, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 4, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 4, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 11, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 11, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 11, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 21, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 21, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 21, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 2, 2025 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Jul 2, 2025 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Jul 2, 2025 | EPEN | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | — |
| Jul 2, 2025 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Jul 1, 2025 | IUAA | USE AMENDMENT ACCEPTED | — |
| Jun 17, 2025 | AUPC | AMENDMENT TO USE PROCESSING COMPLETE | — |
| Jun 17, 2025 | IUAF | USE AMENDMENT FILED | — |
| Jun 17, 2025 | EAAU | TEAS AMENDMENT OF USE RECEIVED | — |
| May 27, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 27, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 27, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 25, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 25, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 25, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 18, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 5, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 29, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 29, 2024 | NWAP | NEW APPLICATION ENTERED | — |